Sponsor Pipeline

Ferring Pharmaceuticals Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
8
Active Trials
6
Recruiting
3
Phase 3
1
Disease Areas
5
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-07 NCT06510374
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk…
Trial sites expanded: 103 -> 106 locations
2026-07-30 NCT04113382
Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy
Enrollment increased: 30 -> 39 participants
2026-07-30 NCT04113382
Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy
Trial arms changed: 4 -> 6
2026-07-30 NCT04113382
Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy
date change Primary completion pushed: 2027-06 -> 2027-12
2026-07-30 NCT04113382
Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy
date change Completion pushed: 2027-06 -> 2027-12
Active Trials by Phase
Phase 3
3
Phase 1/2
2
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06510374 Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk… Intermediate Risk Non-Muscle Invasive Bladder Cancer Recruiting
NCT06545955 A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With… Non-muscle Invasive Bladder Cancer With Carcinoma in Situ Recruiting
NCT05704244 Safety and Efficacy of FE 999326 Administered Intravesically to Japanese Subjects With… Bladder Cancer Active, Not Recruiting
Phase 1/2
NCT06668493 Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis Low-grade Upper Tract Urothelial Carcinoma Recruiting
NCT04113382 Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy Bowel Preparation Recruiting
Not specified
NCT06545877 REKOVELLE PEN for S.C. Injection General Drug Use Survey (Controlled Ovarian Stimulation… Infertility Recruiting
NCT07029451 To Investigate REKOVELLE in Chinese Women Undergoing Assisted Reproductive Technologies… Infertility Recruiting
NCT06561958 Prospective, Multi-centre, Non-Interventional Study to Investigate the Effectiveness of… Infertility Active, Not Recruiting
Disease Areas
Get alerts when Ferring Pharmaceuticals's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free